Loading...

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China

The study aims to examine the treatment effect and adverse reactions of patients with newly diagnosed MM receiving different bortezomib-based regimens. This was a retrospective study of patients with newly diagnosed MM and who were treated with bortezomib-based combined chemotherapy at the Departmen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Medicine (Baltimore)
Main Authors: Yao, Rongxin, Hu, Xudong, Zhou, Shuping, Zhang, Qianying, Huang, He, Sun, Ni, Guo, Wenjian, Yu, Kang, Lin, Ying
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer Health 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6775427/
https://ncbi.nlm.nih.gov/pubmed/31574817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000017147
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!